​

Funding Round

Series A - Eyestem

Series A - Eyestem

Investment Firm

Overview

Eyestem is a cell therapy company founded by a top-class management team.

Announced Date

Aug 08, 2022

Funding Type

Series A

Highlights

Location

India, Asia

Social

Investor Lead

Alkem Laboratories

Alkem Laboratories

No designation

Biological E.

Biological E.

No designation

Natco Pharma

Natco Pharma

No designation

Participant Investors

7

Investor Name
Participant InvestorBiological E.
Participant InvestorAlkem Laboratories
Participant InvestorKaran Bagaria
Participant InvestorAnurag Bagaria
Participant InvestorEndiya Partners

Round Details and Background

Eyestem raised $6406866 on 2022-08-08 in Series A

Eyestem is a cell therapy company founded by a top-class management team.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 25, 2019
Seed Round - Eyestem
4-undefined
May 25, 2021
Seed Round - Eyestem
1-undefined
Aug 08, 2022
Series A - Eyestem
7-6.4M

Recent Activity

There is no recent news or activity for this profile.